ECRD 2026: Navigating the rare disease diagnostic and drug development maze - Pharmaceutical Technology

While rare disease research has advanced significantly, related expertise and data are scattered across too many disconnected places. While rare disease research has advanced significantly, related expertise and data are scattered across too many disconnected places. Fragmentation is limiting the progress of rare disease diagnosis, rather than scientific knowledge, in the pharmaceutical industry. Image credit: [Faizal Ramli]/Shutterstock.com The diagnostic odyssey describes the long journey that patients with rare diseases go through, starting from their first symptom up until a confirmed diagnosis, spanning several years and misdiagnoses along the way. Diagnosis is the foundation for patients’ access to care, social support,…

Source: Pharmaceutical Technology